Decibel Therapeutics, Inc.
DBTXDelisted Sep 25, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001656536
Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Decibel Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −2 vs. Q2 2022
- Shares held
- 17.9M
- +72.5K (+0.4%) vs. Q2 2022
- Total value
- $62.1M
- −$13.1M (−17.5%) vs. Q2 2022
- New holders
- 4
- 10 more added
- Sold out
- 6
- 11 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DBTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $36.4K |
| Q3 2023 | 1 | $36.4K |
| Q2 2023 | 37 | $59.2M |
| Q1 2023 | 38 | $46.7M |
| Q4 2022 | 39 | $35.8M |
| Q3 2022 | 40 | $62.1M |
| Q2 2022 | 42 | $75.2M |
| Q1 2022 | 39 | $53.8M |
| Q4 2021 | 40 | $81.7M |
| Q3 2021 | 36 | $145.9M |
| Q2 2021 | 46 | $168.1M |
| Q1 2021 | 54 | $226.3M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Decibel Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 86 | $0 | 0.00% | +38+79.2% | Added |
| Royal Bank of Canada | 85 | $0 | 0.00% | +85 | New |
| Citigroup Inc | 291 | $1.00K | 0.00% | −1,878−86.6% | Reduced |
| Financial Connections Group, Inc. | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 233 | $1.00K | 0.00% | +233 | New |
| Simplex Trading, LLC | 715 | $2.00K | 0.00% | −387−35.1% | Reduced |
| Bank of America Corp | 5,264 | $19.0K | 0.00% | −5,683−51.9% | Reduced |
| Flagship Harbor Advisors, LLC | 10,113 | $35.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 10,345 | $36.0K | 0.00% | +10,345 | New |
| Laurion Capital Management LP | 11,990 | $41.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 11,698 | $41.0K | 0.00% | +11,082+1,799.0% | Added |
| Morgan Stanley | 12,072 | $42.0K | 0.00% | +1,043+9.5% | Added |
| State Street Corp | 17,160 | $59.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 18,043 | $62.0K | 0.00% | +3,804+26.7% | Added |
| Marquette Asset Management, LLC | 19,783 | $68.0K | 0.02% | −5,921−23.0% | Reduced |
| Federated Hermes, Inc. | 20,000 | $69.0K | 0.00% | 00.0% | Unchanged |
| Atlas Capital Advisors LLC | 25,000 | $86.5K | 0.02% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 27,732 | $95.0K | 0.00% | +422+1.5% | Added |
| Renaissance Technologies LLC | 32,300 | $112.0K | 0.00% | +4,700+17.0% | Added |
| Dimensional Fund Advisors LP | 41,341 | $143.0K | 0.00% | +41,341 | New |
| Bridgeway Capital Management, LLC | 61,982 | $214.0K | 0.01% | −50,000−44.7% | Reduced |
| Neuberger Berman Group LLC | 68,600 | $237.0K | 0.00% | −400−0.6% | Reduced |
| Geode Capital Management, LLC | 111,397 | $385.0K | 0.00% | +40,594+57.3% | Added |
| JPMorgan Chase & Co | 142,259 | $492.0K | 0.00% | −5,965−4.0% | Reduced |
| UBS Oconnor LLC | 157,745 | $546.0K | 0.01% | +70,000+79.8% | Added |
| Bronte Capital Management Pty Ltd. | 163,547 | $566.0K | 0.07% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 213,107 | $737.0K | 0.01% | −11,893−5.3% | Reduced |
| EAM Investors, LLC | 236,966 | $820.0K | 0.18% | −18,015−7.1% | Reduced |
| Barclays PLC | 239,477 | $829.0K | 0.00% | 00.0% | Unchanged |
| Newtyn Management, LLC | 300,000 | $1.04M | 0.23% | −10,000−3.2% | Reduced |
| Millennium Management LLC | 317,292 | $1.10M | 0.00% | +52,720+19.9% | Added |
| Harvard Management Co Inc | 328,798 | $1.14M | 0.14% | 00.0% | Unchanged |
| Bessemer Group Inc | 494,071 | $1.71M | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 622,937 | $2.15M | 0.00% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 801,629 | $2.77M | 0.65% | 00.0% | Unchanged |
| Alphabet Inc. | 1,636,258 | $5.66M | 0.29% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,808,986 | $6.26M | 0.01% | +16,678+0.9% | Added |
| BlackRock Inc. | 1,886,840 | $6.53M | 0.00% | −7,641−0.4% | Reduced |
| TRV GP III, LLC | 3,139,685 | $10.9M | 4.74% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,945,192 | $17.1M | 0.34% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −17,683−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −16,600−100.0% | Sold out |
| MYDA Advisors LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| CSS LLC | 0 | $0 | 0.00% | −10,800−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,504−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −1,240−100.0% | Sold out |